Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework

被引：35

作者：

Okai, D. ^{[2
]}

Samuel, M. ^{[3
,4
]}

Askey-Jones, S. ^{[2
]}

David, A. S. ^{[2
]}

Brown, R. G. ^{[1
]}

机构：

[1] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England

[2] Kings Coll London, Inst Psychiat, Sect Cognit Psychiat, London WC2R 2LS, England

[3] E Kent NHS Fdn Trust, Ashford, Kent, England

[4] NHS Fdn Trust, Kings Coll Hosp, Dept Neurol, London, England

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2011年 / 18卷 / 12期

关键词：

addiction; diagnosis; disinhibition; dysphoria; gambling; hypersexuality; severity; PREFRONTAL CORTEX; DECISION-MAKING; PREVALENCE; ACTIVATION; BEHAVIOR; DEFICITS; THERAPY; STATES; MODEL;

D O I：

10.1111/j.1468-1331.2011.03432.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background: Impulse control disorders (ICDs) and dopamine dysregulation syndrome (DDS) in Parkinsons disease are motivation-based behaviours that involve repetitive occurrences of impulsive and uncontrolled activity. Psychiatric classification is currently inconsistent and unclear. An accurate conceptualisation of these problems is important to guide research and treatment.

引用

页码：1379 / 1383

页数：5

共 50 条

[41] Impulse-Control Disorders in Parkinson's Disease
Ferrara, Joseph M.
Stacy, Mark
CNS SPECTRUMS, 2008, 13 (08) : 690 - 698
[42] Genetics of impulse control disorders in Parkinson’s disease
Florence Cormier
Julia Muellner
Jean-Christophe Corvol
Journal of Neural Transmission, 2013, 120 : 665 - 671
[43] Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease
Joutsa, Juho
Martikainen, Kirsti
Vahlberg, Tero
Kaasinen, Valtteri
PARKINSONISM & RELATED DISORDERS, 2012, 18 (10) : 1079 - 1083
[44] Incidence and severity of impulse control disorders in Parkinson's disease patients treated with dopamine agonists
Rodriguez-Oroz, M. C.
Ribacoba Montero, R.
Rojo-Sebastian, A.
Sesar Ignacio, A.
Delgado-Alvarado, M.
Ares Pensado, B.
MOVEMENT DISORDERS, 2015, 30 : S62 - S62
[45] An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson's disease
Yamanishi, Y.
Ando, R.
Yamasaki, C.
Tada, S.
Miyaue, N.
Iwaki, H.
Yabe, H.
Nishikawa, N.
Nagai, M.
Nomoto, M.
MOVEMENT DISORDERS, 2017, 32
[46] Longitudinal analysis of the relation of dopamine agonist use with impulse control disorders in Parkinson's disease
Corvol, J. C.
Artaud, F.
Rascol, O.
Durif, F.
Derkinderen, P.
Bourdain, F.
Brandel, J. -P.
Pico, F.
Lacomblez, L.
Bonnet, C.
Grabli, D.
Klebe, S.
Mangone, G.
You, H.
Mesnage, V.
Lee, P. C.
Brice, A.
Vidailhet, M.
Cormier-Dequaire, F.
Elbaz, A.
MOVEMENT DISORDERS, 2017, 32
[47] Are Parkinson's disease patients taking dopamine agonists counselled and monitored for impulse control disorders?
Cosgrove, J.
Gilmore, C.
JOURNAL OF NEUROLOGY, 2010, 257 : S214 - S214
[48] Reduced Striatal Dopamine Transporter Availability is Associated with Reduced Impulse Control and the Development of Impulse Control Disorders in Parkinson'S Disease
Vriend, Chris
Gerrits, Niels J. H. M.
van der Werf, Ysbrand D.
Raijmakers, Pieter
Veltman, Dick J.
Berendse, Henk W.
van den Heuvel, Odile A.
BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 174S - 174S
[49] TaqI A polymorphism of the dopamine D2 receptor gene (DRD2), dopamine dysregulation syndrome and impulse control disorders in Parkinson's disease in Poland
Opala, G.
Gorzkowska, A.
Jasinska-Myga, B.
Klodowska-Duda, G.
Bialecka, M.
Kurzawski, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 103 - 103
[50] Impulse control disorders in Parkinson's disease: A case control study
Valenca, G.
Glass, P.
Negreiros, N.
Duarte, M.
Ventura, L.
Mueller, M.
Oliveira-Filho, J.
MOVEMENT DISORDERS, 2011, 26 : S116 - S116

← 1 2 3 4 5 →